Art
J-GLOBAL ID：201102232206822510   Reference number：11A1993459

Coping with uncertainty: T1a,bN0M0 HER2-positive breast cancer, do we have a treatment threshold?

不確実性への対処:T1a,bN0M0 HER2陽性乳癌,治療閾値はあるか?
Author (6)：
KELLY C.M.

About KELLY C.M.

(Watertord Regional Hospital, Waterford, IRL)

About Watertord Regional Hospital, Waterford, IRL

, 
PRITCHARD K.I.

About PRITCHARD K.I.

(Sunnybrook Health Sci. Centre, Toronto, CAN)

About Sunnybrook Health Sci. Centre, Toronto, CAN

, 
TRUDEAU M.

About TRUDEAU M.

(Sunnybrook Health Sci. Centre, Toronto, CAN)

About Sunnybrook Health Sci. Centre, Toronto, CAN

, 
ANDREOPOULOU E.

About ANDREOPOULOU E.

(M.D. Anderson Cancer Center, Houston, USA)

About M.D. Anderson Cancer Center, Houston, USA

, 
HESS K.

About HESS K.

(M.D. Anderson Cancer Center, Houston, USA)

About M.D. Anderson Cancer Center, Houston, USA

, 
PUSZTAI L.

About PUSZTAI L.

(M.D. Anderson Cancer Center, Houston, USA)

About M.D. Anderson Cancer Center, Houston, USA


Material：
Annals of Oncology  (Ann Oncol)

About Annals of Oncology


Volume： 22  Issue： 11  Page： 2387-2393  Publication year： Nov. 2011 
JST Material Number： W0107A  ISSN： 0923-7534  CODEN： ANONE2  Document type： Article
Article type： 短報  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)
Thesaurus term：
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
*breast tumor

About breast tumor

,...
Semi thesaurus term：
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
five-year disease-free survival rate

About five-year disease-free survival rate

,...
Register(free) or Log In to access 

Please login to MyJ-GLOBAL to see full information. You also need to select "Display abstract, etc. of medical articles" in your MyJ-GLOBAL account page in order to see abstracts, etc. of medical articles.

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=11A1993459&from=J-GLOBAL&jstjournalNo=W0107A") }}
JST classification (2)：
JST classification
Category name(code) classified by JST.
Treatment for tumors in general 
(GE03031L)

About Treatment for tumors in general

,  Clinical application of antitumor(=antineoplastic)drugs 
(GW16020L)

About Clinical application of antitumor(=antineoplastic)drugs

Reference (38)：
  • McNeil BJ. Shattuck Lecture-hidden barriers to improvement in the quality of care. N Engl J Med 2001; 345: 1612-1620.
  • Burstein HJ, Winer EP. Refining therapy for human epidermal growth factor receptor 2-positive breast cancer: T stands for trastuzumab, tumor size, and treatment strategy. J Clin Oncol 2009; 27: 5671-5673.
  • Petrelli F, Barni S. Should adjuvant trastuzumab be offered in very early-stage (pT1a/bN0M0) HER2-neu-positive breast cancer? A current debate. Med Oncol 2010. [Epub ahead of print] doi:10.1007/s12032-010-9460-0.
  • Piccart-Gebhart MJ, Procter M, Leyland-Jones B et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 2005;353: 1659-1672.
  • Romond EH, Perez EA, Bryant J et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 2005; 353: 1673-1684.
ｍore...
Terms in the title (5)：
Terms in the title
Keywords automatically extracted from the title.
不確実性

About 不確実性

, 
対処

About 対処

, 
HER2陽性乳癌

About HER2陽性乳癌

, 
治療

About 治療

, 
閾値

About 閾値


Return to Previous Page

TOP

BOTTOM